Dynamk Capital is a venture capital and growth equity firm investing in life science companies.  Dynamk's investment strategy is centered on Life Science Industrials: companies developing disruptive technologies, tools, and services that enable the full biopharma continuum across discovery, development, and manufacturing of therapeutics.  The Dynamk team includes experienced life science entrepreneurs, investors, advisors, and subject matter experts and is headquartered in New York City.